tiprankstipranks
Coherus Biosciences (CHRS)
NASDAQ:CHRS
US Market
CHRS
Coherus Biosciences
RESEARCH TOOLSreports

Coherus Biosciences (CHRS) Financial Statements

Compare
1,659 Followers

Coherus Biosciences Financial Overview

Coherus Biosciences's market cap is currently $244.32M. The company's EPS TTM is $-0.39; its P/E ratio is -1.00; Coherus Biosciences is scheduled to report earnings on March 9, 2026, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 42.17M$ 266.96M$ 257.24M$ 211.04M$ 326.55M
Gross Profit$ 28.36M$ 149.41M$ 98.25M$ 140.96M$ 268.96M
Operating Income$ -181.13M$ -111.67M$ -203.20M$ -256.88M$ -263.86M
EBITDA$ -170.20M$ 60.94M$ -193.94M$ -255.58M$ -260.69M
Net Income$ -170.29M$ 28.51M$ -237.89M$ -291.75M$ -287.10M
Balance Sheet
Cash & Short-Term Investments$ 172.13M$ 125.99M$ 117.75M$ 191.68M$ 417.19M
Total Assets$ 258.34M$ 448.53M$ 629.60M$ 480.85M$ 679.33M
Total Debt$ 40.34M$ 269.90M$ 480.84M$ 480.42M$ 419.02M
Net Debt$ -48.54M$ 143.92M$ 377.95M$ 416.88M$ 1.83M
Total Liabilities$ 197.33M$ 580.52M$ 823.03M$ 618.26M$ 581.61M
Stockholders' Equity$ 61.01M$ -131.99M$ -193.43M$ -137.42M$ 97.73M
Cash Flow
Free Cash Flow$ -138.51M$ -20.44M$ -175.17M$ -243.16M$ -38.72M
Operating Cash Flow$ -138.51M$ -20.44M$ -174.88M$ -241.12M$ -37.43M
Investing Cash Flow$ 375.09M$ 230.32M$ 144.64M$ -166.85M$ -138.41M
Financing Cash Flow$ -273.70M$ -186.97M$ 69.60M$ 54.33M$ 51.88M
Currency in USD

Coherus Biosciences Earnings and Revenue History

Income Statement >

Coherus Biosciences Debt to Assets

Balance Sheet >

Coherus Biosciences Cash Flow

Cash Flow >

Coherus Biosciences Forecast EPS vs Actual EPS

Earnings >